Latest News / Abiraterone Acetate NewsStream Add Bookmark

Latest articles for Abiraterone Acetate, as of Thu Apr 17.Want Email Updates? Just use the 'Daily Updates' box on the right!. Below that is a more extensive toolbox that allows you to filter and triage these articles.
Coloured tags show you key topics (e.g. Indications, Drugs, Targets, Companies) also mentioned in the article. Click a tag to see its own NewsStream, or the '' link to create a NewsStream that specifically mentions the two topics together.


 
Prevention Of Prostate Carcinogenesis By NEXT-Generation Selenium (Texas Tech University Health Scis Center, Lubbock, United States)

NIH Grant #8625728 (TEXAS TECH UNIVERSITY HEALTH SCIS CENTER, LUBBOCK,...  (1 day ago)

Grant: Expand | View [This Window] [New Window]
 
Trinidad & Tobago Ministry Of Health Approves Janssen's Prostate Cancer Drug Zytiga

Pharma Business Review  (2 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
New Therapy For Advanced Prostate Cancer Approved In Trinidad & Tobago

CWA  (3 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
New Therapy For Advanced Prostate Cancer Available In Trinidad & Tobago

PRNEWSWIRE  (5 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
ARN 509 Plus Everolimus In Men With Progressive Metastatic CASTRATION-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

ClinicalTrials.gov Trial Updates Record#NCT02106507 [Sponsor:Memorial ...  (9 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
5 Biotechs With Prostate Cancer Treatments Worth Watching - Motley Fool

Drug Web Reports  (11 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
 
Bayer Initiates PHASE 3 Trial Of Xofigo (Radium RA 223 Dichloride) Injection In Combination With Abiraterone Acetate For Asymptomatic Or Mildly Symptomatic CHEMOTHERAPY-Naive Patients With Bone Predominant Metastatic CASTRATION-Resistant Prostate C

PRNEWSWIRE  (15 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Is It Possible That One Patient May Again Experience A Response To Abiraterone Acetate Withdrawal During An Abiraterone Acetate Rechallenge

Maines F et al Eur Urol. 2014 Mar 24. pii: S0302-2838(14)00264-4. doi:...  (15 days ago)

Publication: Expand | View [This Window] [New Window]
 
Hormonal Therapeutics Enzalutamide And Abiraterone Acetate In The Treatment Of Metastatic CASTRATION-Resistant Prostate Cancer (Mcrpc) POST-DOCETAXEL-An Indirect Comparison

Tan PS et al Clin Med Insights Oncol. 2014 Mar 16;8:29-36. doi: 10.413...  (19 days ago)

Publication: Expand | View [This Window] [New Window]
 
Open Label Phase Two Trial Of Radium RA 223 Dichloride With Concurrent Administration Of Abiraterone Acetate Plus Prednisone In Symptomatic CASTRATION-Resistant (HORMONE-Refractory) Prostate Cancer Subjects With Bone Metastasis

ClinicalTrials.gov Trial Updates Record#NCT02097303 [Sponsor:Carolina ...  (21 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
A Cancer Research Uk Phase I/II Open Label Study To Evaluate The Safety, Endocrine Effects, And ANTI-Tumour Activity Of Abiraterone Acetate (CB7630) In Patients With Oestrogen (Er) Or Androgen Rece...

EuCTR Trial Updates Record#2007-003240-30 [Sponsor:Cancer Research UK]  (24 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
Updated Interim Efficacy Analysis And LONG-Term Safety Of Abiraterone Acetate In Metastatic CASTRATION-Resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)

Rathkopf DE et al Eur Urol. 2014 Mar 6. pii: S0302-2838(14)00185-7. do...  (26 days ago)

Publication: Expand | View [This Window] [New Window]
 
A Phase III Randomized, DOUBLE-Blind, PLACEBO-Controlled Trial Of RADIUM-223 Dichloride In Combination With Abiraterone Acetate And Prednisone/Prednisolone In The Treatment Of Asymptomatic Or Mildl...

EuCTR Trial Updates Record#2013-003438-33 [Sponsor:Bayer HealthCare AG...  (28 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
Androgen Dynamics And Serum Psa In Patients Treated With Abiraterone Acetate

Ryan CJ et al Prostate Cancer Prostatic Dis. 2014 Mar 18. doi: 10.1038...  (29 days ago)

Publication: Expand | View [This Window] [New Window]
 
RE-Sensitizing With Supraphysiologic Testosterone To Overcome Resistant (The Restore Study)

ClinicalTrials.gov Trial Updates Record#NCT02090114 [Sponsor:Sidney Ki...  (30 days ago)

Clinical Trial: Expand | View [This Window] [New Window]
 
Growing Role For ANDROGEN-Targeting Therapies In Crpc - Onclive

Drug Web Reports  (30 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
 
The Economics Of Abiraterone Acetate For CASTRATION-Resistant Prostate Cancer

Dellis A and Papatsoris AG Expert Rev Pharmacoecon Outcomes Res. 2014 ...  (50 days ago)

Publication: Expand | View [This Window] [New Window]
 
Outcomes With Abiraterone Acetate In Metastatic CASTRATION-Resistant Prostate Cancer Patients Who Have Poor Performance Status

Azad AA et al Eur Urol. 2014 Jan 31. pii: S0302-2838(14)00099-2. doi: ...  (65 days ago)

Publication: Expand | View [This Window] [New Window]
 
Zytiga Now Reimbursed In Quebec For Use Prior To Chemotherapy In Men With Metastatic Prostate Cancer

Pharma Business Review  (69 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Initial Experience With Abiraterone Acetate In Patients With CASTRATION-Resistant Prostate Cancer

Beardo-Villar P et al Actas Urol Esp. 2014 Jan 27. pii: S0210-4806(13)...  (75 days ago)

Publication: Expand | View [This Window] [New Window]
 
Positive Results For Prostate Cancer Treatment With Xtandi - Monthly Prescribing Reference

Drug Web Reports  (76 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
New Data Positions Astellas Prostate Cancer Med Xtandi To Grab Market Share From J&J's Zytiga

FiercePharma  (78 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Medivation Still Prevailing - Dailyfinance

Drug Web Reports  (78 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Drug Shows Promise In Advanced Prostate Cancer When Used Before Chemotherapy

NY Times Health  (78 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Medivation Still Prevailing - Motley Fool

Drug Web Reports  (78 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Clinical Variables Associated With Psa Response To Abiraterone Acetate In Patients With Metastatic CASTRATION-Resistant Prostate Cancer

Leibowitz-Amit R et al Ann Oncol. 2014 Jan 23.  (82 days ago)

Publication: Expand | View [This Window] [New Window]
 
Strong Showing For J&J's Pharma Unit - Pharmatimes

PharmaTimes  (83 days ago)

Web/News Item: Expand | View [This Window] [New Window]
 
Strong Showing For J&J's Pharma Unit - Pharmatimes

PharmaTimes  (84 days ago)

Web/News Item: Expand | View [This Window] [New Window]

Next >

Topic Activity [last 90 days]

Please wait... If the chart does not appear, try updating your browser, ensuring javasript is turned turned on

  Daily Alerts!

 Get Regular Updates By:  Email or RSS

[Need Help With RSS?]
 About This Topic  Data Mining Tools  My Recent Topics  Quick Help

Sponsored Links


Interested in sponsoring our site or advertising with us? Be a part of SciBites growing success. Contact Us Today.



View as RDF